133 related articles for article (PubMed ID: 22350405)
1. The clinical efficacy and safety of micafungin-itraconazole combination therapy in patients with pulmonary aspergilloma.
Fujita M; Tao Y; Kajiki A; Ouchi H; Harada E; Ikegame S; Matsumoto T; Uchino J; Watanabe K; Nakanishi Y
J Infect Chemother; 2012 Oct; 18(5):668-74. PubMed ID: 22350405
[TBL] [Abstract][Full Text] [Related]
2. [Short-term efficacy evaluation of chronic pulmonary aspergillosis treated with micafangin and maintenance therapy of itraconazole].
Yasuda S; Ohnishi R; Suzuki T; Sano K; Kato T
Nihon Kokyuki Gakkai Zasshi; 2009 Nov; 47(11):985-90. PubMed ID: 19994592
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
Izumikawa K; Ohtsu Y; Kawabata M; Takaya H; Miyamoto A; Sakamoto S; Kishi K; Tsuboi E; Homma S; Yoshimura K
Med Mycol; 2007 May; 45(3):273-8. PubMed ID: 17464848
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy and safety of micafungin in Japanese patients with chronic pulmonary aspergillosis: a prospective observational study.
Kohno S; Izumikawa K; Kakeya H; Miyazaki Y; Ogawa K; Amitani R; Niki Y; Kurashima A
Med Mycol; 2011 Oct; 49(7):688-93. PubMed ID: 21355713
[TBL] [Abstract][Full Text] [Related]
5. [An open, noncomparative multicenter study of the efficacy and safety of itraconazole injections and high dose capsules in chronic pulmonary aspergillosis].
Tomioka H; Kaneda T; Kida Y; Kaneko M; Fujii H; Hayashi M; Tomii K; Tada K; Suzuki Y; Karino T
Kansenshogaku Zasshi; 2011 Nov; 85(6):644-51. PubMed ID: 22250455
[TBL] [Abstract][Full Text] [Related]
6. Clinical effects of micafungin, a novel echinocandin antifungal agent, on systemic fungal infections in surgery, emergency, and intensive-care medicine: evaluation using the AKOTT algorithm.
Aikawa N; Kusachi S; Oda S; Takesue Y; Tanaka H
J Infect Chemother; 2009 Aug; 15(4):219-27. PubMed ID: 19688240
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of micafungin for febrile neutropenia in pediatric patients with hematological malignancies: a multicenter prospective study.
Kobayashi R; Suzuki N; Yoshida M; Iizuka S; Suzuki D; Sano H; Kudoh T
J Pediatr Hematol Oncol; 2013 Oct; 35(7):e276-9. PubMed ID: 23743960
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study.
Jeong SH; Kim DY; Jang JH; Mun YC; Choi CW; Kim SH; Kim JS; Park JS
Ann Hematol; 2016 Jan; 95(2):337-44. PubMed ID: 26596974
[TBL] [Abstract][Full Text] [Related]
9. Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan.
Kohno S; Izumikawa K; Ogawa K; Kurashima A; Okimoto N; Amitani R; Kakeya H; Niki Y; Miyazaki Y;
J Infect; 2010 Nov; 61(5):410-8. PubMed ID: 20797407
[TBL] [Abstract][Full Text] [Related]
10. [Correlations between drug plasma concentration and adverse effects in patients treated with itraconazole for pulmonary aspergilloma].
Maesaki S; Hashiguchi K; Tomiyama Y; Sasaki E; Miyazaki H; Miyazaki Y; Higashiyama Y; Tomono K; Tashiro T; Kohno S
Nihon Kokyuki Gakkai Zasshi; 1999 Nov; 37(11):875-9. PubMed ID: 18217308
[TBL] [Abstract][Full Text] [Related]
11. Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature.
Agarwal R; Vishwanath G; Aggarwal AN; Garg M; Gupta D; Chakrabarti A
Mycoses; 2013 Sep; 56(5):559-70. PubMed ID: 23496375
[TBL] [Abstract][Full Text] [Related]
12. Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant.
Huang X; Chen H; Han M; Zou P; Wu D; Lai Y; Huang H; Chen X; Liu T; Zhu H; Wang J; Hu J
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1509-16. PubMed ID: 22469884
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of short- and long-term treatment of itraconazole on chronic necrotizing pulmonary aspergillosis in multicenter study.
Yoshida K; Kurashima A; Kamei K; Oritsu M; Ando T; Yamamoto T; Niki Y
J Infect Chemother; 2012 Jun; 18(3):378-85. PubMed ID: 22526387
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of micafungin, an echinocandin antifungal agent, on invasive fungal infections in patients with hematological disorders.
Tamura K; Urabe A; Yoshida M; Kanamaru A; Kodera Y; Okamoto S; Maesaki S; Masaoka T
Leuk Lymphoma; 2009 Jan; 50(1):92-100. PubMed ID: 19172498
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study.
Yamaguchi M; Kurokawa T; Ishiyama K; Aoki G; Ueda M; Matano S; Takami A; Yamazaki H; Sawazaki A; Yamauchi H; Yoshida T; Nakao S
Ann Hematol; 2011 Oct; 90(10):1209-17. PubMed ID: 21695388
[TBL] [Abstract][Full Text] [Related]
16. First case report of acquired pure red cell aplasia associated with micafungin.
Yoshida-Hiroi M; Koizumi M; Oka R; Mitsuda A; Hiroi N
Intern Med; 2011; 50(9):1051-4. PubMed ID: 21532231
[TBL] [Abstract][Full Text] [Related]
17. [Combination therapy of micafungin and itraconazole for a case of pulmonary aspergillosis].
Maruyama T; Takagi T; Yuda H
Nihon Kokyuki Gakkai Zasshi; 2005 Feb; 43(2):94-8. PubMed ID: 15770940
[TBL] [Abstract][Full Text] [Related]
18. [Case of chronic necrotizing pulmonary aspergillosis complicated by elevated eosinophils and serum IgE].
Morita H; Oguri T; Uemura T; Iwashima Y; Nakamura A; Sato S
Nihon Kokyuki Gakkai Zasshi; 2010 Nov; 48(11):842-6. PubMed ID: 21141064
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of micafungin versus extensive azoles in the prevention and treatment of invasive fungal infections for neutropenia patients with hematological malignancies: A meta-analysis of randomized controlled trials.
Lee CH; Lin JC; Ho CL; Sun M; Yen WT; Lin C
PLoS One; 2017; 12(7):e0180050. PubMed ID: 28700646
[TBL] [Abstract][Full Text] [Related]
20. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients.
Zaoutis TE; Jafri HS; Huang LM; Locatelli F; Barzilai A; Ebell W; Steinbach WJ; Bradley J; Lieberman JM; Hsiao CC; Seibel N; Laws HJ; Gamba M; Petrecz M; Taylor AF; Strohmaier KM; Chow JW; Kartsonis NA; Ngai AL
Pediatrics; 2009 Mar; 123(3):877-84. PubMed ID: 19255017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
